Journey Medical Corp (DERM) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
DERM currently has 6M outstanding shares. with significant dilution risk as 12.3M authorized shares could dilute existing holders by 205.5%. The company has significantly diluted shareholders by 354.28% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 13, 2026 |
10-Q filing | 6.0M shares outstanding |
6M | 12M |
| Jan 15, 2026 |
S-3 filing: This S-3 filing from 2026-01-15 details a shelf registration for up to $150 million in common stock, preferred stock, and debt securities, with the potential for offerings to be made from time to time at prices and terms determined at the time of the offering. |
27M | 12M |
| Nov 12, 2025 |
10-Q filing | 6.0M shares outstanding |
6M | 8.6M |
| Aug 12, 2025 |
10-Q filing | 6.0M shares outstanding |
6M | 8.6M |
| May 15, 2025 |
10-Q filing | 6.0M shares outstanding |
6M | 8.6M |
| Mar 27, 2025 |
10-K filing | 6.0M shares outstanding |
6M | 8.6M |
| Nov 12, 2024 |
10-Q filing | 6.0M shares outstanding |
6M | 8.6M |
| Aug 13, 2024 |
10-Q filing | 6.0M shares outstanding |
6M | 8.6M |
| May 14, 2024 |
10-Q filing | 6.0M shares outstanding |
6M | 8.6M |
| Mar 29, 2024 |
10-K filing | 6.0M shares outstanding |
6M | 8.6M |
| Nov 13, 2023 |
10-Q filing | 12.5M shares outstanding |
12M | 8.6M |
| Aug 10, 2023 |
10-Q filing | 12.1M shares outstanding |
12M | 8.6M |
| May 22, 2023 |
10-Q filing | 11.8M shares outstanding |
12M | 8.6M |
| Mar 31, 2023 |
10-K filing | 6.0M shares outstanding |
6M | 8.6M |
| Jan 03, 2023 |
8-K filing: Journey Medical Corporation entered into an At Market Issuance Sales Agreement with B. Riley Securities, Inc., under which the Company may offer and sell up to 4,900,000 shares of its common stock from time to time. |
12M | 8.6M |
| Dec 30, 2022 |
S-3 filing: Journey Medical Corporation is filing an S-3 to offer up to $150 million in common stock, preferred stock, debt securities, warrants and/or units, as well as offering up to 4,900,000 shares of common stock through an at-the-market offering with B. Riley as the sales agent. |
12M | 8.6M |
| Nov 10, 2022 |
10-Q filing | 11.6M shares outstanding |
12M | 3.7M |
| Aug 09, 2022 |
10-Q filing | 11.6M shares outstanding |
12M | 3.7M |
| May 10, 2022 |
10-Q filing | 6.0M shares outstanding |
6M | 3.7M |
| Mar 28, 2022 |
10-K filing | 6.0M shares outstanding |
6M | 3.7M |
| Dec 16, 2021 |
10-Q filing | 6.0M shares outstanding |
6M | 3.7M |
| Nov 12, 2021 |
8-K filing: Journey Medical Corporation sold 3,520,000 shares of common stock at $10.00 per share in an underwritten offering for gross proceeds of $35,520,000. The company also filed the Third Amended and Restated Certificate of Incorporation. ($35.52M proceeds) |
9.2M | 3.7M |
| Nov 10, 2021 |
S-1/A filing: This S-1/A filing is for an initial public offering of common stock with 3,200,000 shares offered, and an option for underwriters to purchase up to 480,000 additional shares. |
9.2M | 3.7M |
| Nov 08, 2021 |
S-1/A filing: This is an S-1/A filing for an initial public offering of common stock. |
16M | 3.7M |
| Oct 22, 2021 |
S-1 filing: S-1 filing for an initial public offering of common stock with B. Riley Securities as the sole book-running manager. Roth Capital Partners is also mentioned. The company grants the underwriters an option to purchase additional shares of common stock. |
N/A | 0 |